Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 30 years executive experience including Abbott and JNJ and has been involved three successful start-ups. He has a B.S, from Penn State University and an MBA from... More
My company:
Raygent Capital
My blog:
  • A Good Week For Rayno Life Science Stocks: AMRI, CBST, ILMN, RHHBY 0 comments
    Feb 28, 2014 12:23 AM | about stocks: AMRI, MRK, ILMN

    Rayno Life Science Movers -Diagnostics Review Next Week

    Despite some choppiness in biotech trading this week many of our stocks did well. I won't go into some of the unusual volatility in other small and mid-caps lately but that is part of the reason for my "bubble" article. There is also a lot of focus in the media about soaring biotech stocks with IBB at $272 just shy of 52 week high of $275.

    Here are some Rayno Life Science stocks of note this week. Review the complete list on the Raygent WEB site as many stocks are at new highs.

    Albany Molecular, (AMRI $16) nobody liked this biotech contract services (CRO) stock when we recommended it at $4.68 at a 0.55 P/S less than two years ago. Now the P/S is still only 2. Guidance and 2013 results pleased investors today.

    Cubist, (CBST $81.23) new highs and acceptance of EMA marketing authorization for Tedizolid. Price to Sales only 5.72.

    Illumina, (ILMN $178) momentum stock with news on sequencing app for Downs Syndrome.

    Roche Holdings, (OTCQX:RHHBY $38.50) 2:1 split and new high. Leader in diagnostics and biopharmaceuticals

    ThermoFisher (TMO $124.91) at new highs and recently upgraded.

    XLV ($59.44) a healthcare EFT has rallied from the January bottom and is now up 7.2% YTD.

    New picks since last December are all doing well: Nanostring Technologies (NASDAQ:NSTG), Roche Holdings (RHBBY) and XLV a healthcare ETF.

    Large caps hit new highs recently: ALXN AMGN, BIIB, GILD. Watch the technicals particularly the volatile ETF XBI which holds more of the mid and small caps.

    Our core position Fidelity Select Biotech Find (FBIOX $228.44) is up 25.7% YTD.

    As most 2013 earnings reports are in we will review all Rayno Tools and Diagnostics stocks next week.

    Disclosure: I am long RHHBY.

    Additional disclosure: I am long Fidelity Select Biotech Fund (MUTF:FBIOX)

    Stocks: AMRI, MRK, ILMN
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.